{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:37:22Z","timestamp":1790728642505,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T00:00:00Z","timestamp":1441756800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1634-x","type":"journal-article","created":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T22:22:09Z","timestamp":1441837329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion"],"prefix":"10.1186","volume":"15","author":[{"given":"Niamh M.","family":"Cooke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy D.","family":"Spillane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orla","family":"Sheils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dermot","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,9]]},"reference":[{"key":"1634_CR1","first-page":"1295","volume":"59","author":"B Nieswandt","year":"1999","unstructured":"Nieswandt B, Hafner M, Echtenacher B, Mannel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 1999;59:1295\u2013300.","journal-title":"Cancer Res"},{"key":"1634_CR2","first-page":"1713","volume":"143","author":"C Philippe","year":"1993","unstructured":"Philippe C, Philippe B, Fouqueray B, Perez J, Lebret M, Baud L. Protection from tumor necrosis factor-mediated cytolysis by platelets. Am J Pathol. 1993;143:1713\u201323.","journal-title":"Am J Pathol"},{"key":"1634_CR3","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1073\/pnas.0510412103","volume":"103","author":"J Kisucka","year":"2006","unstructured":"Kisucka J, Butterfield CE, Duda DG, Eichenberger SC, Ware J, Saffaripour S, et al. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci U S A. 2006;103:855\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1634_CR4","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.2353\/ajpath.2008.080474","volume":"173","author":"G Pietramaggiori","year":"2008","unstructured":"Pietramaggiori G, Scherer SS, Cervi D, Klement G, Orgill DP. Tumors stimulate platelet delivery of angiogenic factors in vivo: an unexpected benefit. Am J Pathol. 2008;173:1609\u201316.","journal-title":"Am J Pathol"},{"key":"1634_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cardiores.2005.04.007","volume":"67","author":"A Brill","year":"2005","unstructured":"Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res. 2005;67:30\u20138.","journal-title":"Cardiovasc Res"},{"key":"1634_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/(SICI)1097-0215(19970117)70:2<201::AID-IJC11>3.0.CO;2-L","volume":"70","author":"R Dardik","year":"1997","unstructured":"Dardik R, Kaufmann Y, Savion N, Rosenberg N, Shenkman B, Varon D. Platelets mediate tumor cell adhesion to the subendothelium under flow conditions: involvement of platelet GPIIb-IIIa and tumor cell alpha(v) integrins. Int J Cancer. 1997;70:201\u20137.","journal-title":"Int J Cancer"},{"key":"1634_CR7","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/ijc.24016","volume":"124","author":"O Dashevsky","year":"2009","unstructured":"Dashevsky O, Varon D, Brill A. Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production. Int J Cancer. 2009;124:1773\u20137.","journal-title":"Int J Cancer"},{"key":"1634_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1538-7836.2010.04131.x","volume":"9","author":"NM Bambace","year":"2011","unstructured":"Bambace NM, Holmes CE. The platelet contribution to cancer progression. J Thromb Haemost. 2011;9:237\u201349.","journal-title":"J Thromb Haemost"},{"key":"1634_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11:123\u201334.","journal-title":"Nat Rev Cancer"},{"key":"1634_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1182\/blood-2004-02-0434","volume":"104","author":"E Camerer","year":"2004","unstructured":"Camerer E, Qazi AA, Duong DN, Cornelissen I, Advincula R, Coughlin SR. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood. 2004;104:397\u2013401.","journal-title":"Blood"},{"key":"1634_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1073\/pnas.61.1.46","volume":"61","author":"GJ Gasic","year":"1968","unstructured":"Gasic GJ, Gasic TB, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A. 1968;61:46\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1634_CR12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442\u201354.","journal-title":"Nat Rev Cancer"},{"key":"1634_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S1383-5742(03)00033-4","volume":"566","author":"J Gotzmann","year":"2004","unstructured":"Gotzmann J, Mikula M, Eger A, Schulte-Hermann R, Foisner R, Beug H, et al. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res. 2004;566:9\u201320.","journal-title":"Mutat Res"},{"key":"1634_CR14","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1093\/annonc\/mdm070","volume":"18","author":"M Mimeault","year":"2007","unstructured":"Mimeault M, Batra SK. Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies. Ann Oncol. 2007;18:1605\u201319.","journal-title":"Ann Oncol"},{"key":"1634_CR15","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20:576\u201390.","journal-title":"Cancer Cell"},{"key":"1634_CR16","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.1182\/blood-2012-06-438598","volume":"120","author":"MS Cho","year":"2012","unstructured":"Cho MS, Bottsford-Miller J, Vasquez HG, Stone R, Zand B, Kroll MH, et al. Platelets increase the proliferation of ovarian cancer cells. Blood. 2012;120:4869\u201372.","journal-title":"Blood"},{"key":"1634_CR17","volume-title":"GLOBOCAN 2008 v1.2. Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No 10 [Internet]","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2. Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No 10 [Internet]. Lyon, France: IARC Press; 2010. Available from: http:\/\/globocan.iarc.fr ."},{"key":"1634_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1098-2388(200007\/08)19:1<3::AID-SSU2>3.0.CO;2-S","volume":"19","author":"CH Holschneider","year":"2000","unstructured":"Holschneider CH, Berek JS. Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol. 2000;19:3\u201310.","journal-title":"Semin Surg Oncol"},{"key":"1634_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ygyno.2011.05.028","volume":"122","author":"A Poveda","year":"2011","unstructured":"Poveda A, Kaye SB, McCormack R, Wang S, Parekh, Ricci D, et al. Circulating tumor cells predict progression free survival and overall survival in patients with relapsed\/recurrent advanced ovarian cancer. Gynecol Oncol. 2011;122:567\u201372.","journal-title":"Gynecol Oncol"},{"key":"1634_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","volume":"26","author":"S Pradeep","year":"2014","unstructured":"Pradeep S, Kim SW, Wu SY, Nishimura M, Chaluvally-Raghavan P, Miyake T, et al. Hematogenous metastasis of ovarian cancer: rethinking mode of spread. Cancer Cell. 2014;26:77\u201391.","journal-title":"Cancer Cell"},{"key":"1634_CR21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1200\/JCO.2001.19.2.368","volume":"19","author":"S Braun","year":"2001","unstructured":"Braun S, Schindlbeck C, Hepp F, Janni W, Kentenich C, Riethmuller G, et al. Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse. J Clin Oncol. 2001;19:368\u201375.","journal-title":"J Clin Oncol"},{"key":"1634_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ygyno.2008.09.046","volume":"112","author":"MC Lim","year":"2009","unstructured":"Lim MC, Kang S, Lee KS, Han SS, Park SJ, Seo SS, et al. The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer. Gynecol Oncol. 2009;112:28\u201334.","journal-title":"Gynecol Oncol"},{"key":"1634_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ygyno.2006.03.028","volume":"102","author":"PM Magtibay","year":"2006","unstructured":"Magtibay PM, Adams PB, Silverman MB, Cha SS, Podratz KC. Splenectomy as part of cytoreductive surgery in ovarian cancer. Gynecol Oncol. 2006;102:369\u201374.","journal-title":"Gynecol Oncol"},{"key":"1634_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026125","volume":"6","author":"K Egan","year":"2011","unstructured":"Egan K, Crowley D, Smyth P, O\u2019Toole S, Spillane C, Martin C, et al. Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells. PLoS One. 2011;6, e26125.","journal-title":"PLoS One"},{"key":"1634_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","volume":"377","author":"PM Rothwell","year":"2011","unstructured":"Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011;377:31\u201341.","journal-title":"Lancet"},{"key":"1634_CR26","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","volume":"379","author":"PM Rothwell","year":"2012","unstructured":"Rothwell PM, Price JF, Fowkes FG, Zanchetti A, Roncaglioni MC, Tognoni G, et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet. 2012;379:1602\u201312.","journal-title":"Lancet"},{"key":"1634_CR27","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","volume":"379","author":"PM Rothwell","year":"2012","unstructured":"Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet. 2012;379:1591\u2013601.","journal-title":"Lancet"},{"key":"1634_CR28","doi-asserted-by":"publisher","first-page":"djt431","DOI":"10.1093\/jnci\/djt431","volume":"106","author":"B Trabert","year":"2014","unstructured":"Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, et al. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst. 2014;106:djt431.","journal-title":"J Natl Cancer Inst"},{"key":"1634_CR29","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-11-1872","volume":"72","author":"T Placke","year":"2012","unstructured":"Placke T, Orgel M, Schaller M, Jung G, Rammensee HG, Kopp HG, et al. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. Cancer Res. 2012;72:440\u20138.","journal-title":"Cancer Res"},{"key":"1634_CR30","doi-asserted-by":"publisher","first-page":"16108","DOI":"10.1074\/jbc.M809780200","volume":"284","author":"S Srinivasan","year":"2009","unstructured":"Srinivasan S, Mir F, Huang JS, Khasawneh FT, Lam SC, Le Breton GC. The P2Y12 antagonists, 2-methylthioadenosine 5\u2032-monophosphate triethylammonium salt and cangrelor (ARC69931MX), can inhibit human platelet aggregation through a Gi-independent increase in cAMP levels. J Biol Chem. 2009;284:16108\u201317.","journal-title":"J Biol Chem"},{"key":"1634_CR31","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/sj.bjp.0704559","volume":"135","author":"AW Chung","year":"2002","unstructured":"Chung AW, Jurasz P, Hollenberg MD, Radomski MW. Mechanisms of action of proteinase-activated receptor agonists on human platelets. Br J Pharmacol. 2002;135:1123\u201332.","journal-title":"Br J Pharmacol"},{"key":"1634_CR32","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/sj.bjp.0706013","volume":"143","author":"P Jurasz","year":"2004","unstructured":"Jurasz P, Alonso-Escolano D, Radomski MW. Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol. 2004;143:819\u201326.","journal-title":"Br J Pharmacol"},{"key":"1634_CR33","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1084\/jem.20071082","volume":"204","author":"KG Leong","year":"2007","unstructured":"Leong KG, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I, et al. Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med. 2007;204:2935\u201348.","journal-title":"J Exp Med"},{"key":"1634_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2131","volume":"7","author":"H Peinado","year":"2007","unstructured":"Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7:415\u201328.","journal-title":"Nat Rev Cancer"},{"key":"1634_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1440-169X.2009.01076.x","volume":"51","author":"JL Duband","year":"2009","unstructured":"Duband JL, Blavet C, Jarov A, Fournier-Thibault C. Spatio-temporal control of neural epithelial cell migration and epithelium-to-mesenchyme transition during avian neural tube development. Dev Growth Differ. 2009;51:25\u201344.","journal-title":"Dev Growth Differ"},{"key":"1634_CR36","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420\u20138.","journal-title":"J Clin Invest"},{"key":"1634_CR37","doi-asserted-by":"publisher","first-page":"e915","DOI":"10.1038\/cddis.2013.442","volume":"4","author":"RY Huang","year":"2013","unstructured":"Huang RY, Wong MK, Tan TZ, Kuay KT, Ng AH, Chung VY, et al. An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis. 2013;4:e915.","journal-title":"Cell Death Dis"},{"key":"1634_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/bjc.2014.271","volume":"111","author":"L Alfonso","year":"2014","unstructured":"Alfonso L, Ai G, Spitale RC, Bhat GJ. Molecular targets of aspirin and cancer prevention. Br J Cancer. 2014;111:61\u20137.","journal-title":"Br J Cancer"},{"key":"1634_CR39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ccr.2013.05.008","volume":"24","author":"D Schumacher","year":"2013","unstructured":"Schumacher D, Strilic B, Sivaraj KK, Wettschureck N, Offermanns S. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor. Cancer Cell. 2013;24:130\u20137.","journal-title":"Cancer Cell"},{"key":"1634_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080780","volume":"8","author":"Y Wang","year":"2013","unstructured":"Wang Y, Sun Y, Li D, Zhang L, Wang K, Zuo Y, et al. Platelet P2Y12 is involved in murine pulmonary metastasis. PLoS One. 2013;8, e80780.","journal-title":"PLoS One"},{"key":"1634_CR41","doi-asserted-by":"crossref","unstructured":"Gebremeskel S, Levatte T, Liwski RS, Johnston B, Bezuhly M. The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer. Int J Cancer. 2014.","DOI":"10.1002\/ijc.28947"},{"key":"1634_CR42","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s10585-009-9264-9","volume":"26","author":"CE Holmes","year":"2009","unstructured":"Holmes CE, Levis JE, Ornstein DL. Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis. Clin Exp Metastasis. 2009;26:653\u201361.","journal-title":"Clin Exp Metastasis"},{"key":"1634_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1023\/A:1006190729866","volume":"55","author":"AM Sieuwerts","year":"1999","unstructured":"Sieuwerts AM, Klijn JG, Henzen-Logmans SC, Foekens JA. Cytokine-regulated urokinase-type-plasminogen-activator (uPA) production by human breast fibroblasts in vitro. Breast Cancer Res Treat. 1999;55:9\u201320.","journal-title":"Breast Cancer Res Treat"},{"key":"1634_CR44","first-page":"3201","volume":"17","author":"EI Deryugina","year":"1997","unstructured":"Deryugina EI, Luo GX, Reisfeld RA, Bourdon MA, Strongin A. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res. 1997;17:3201\u201310.","journal-title":"Anticancer Res"},{"key":"1634_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.thromres.2003.10.012","volume":"112","author":"P Jurasz","year":"2003","unstructured":"Jurasz P, North S, Venner P, Radomski MW. Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study. Thromb Res. 2003;112:59\u201364.","journal-title":"Thromb Res"},{"key":"1634_CR46","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1124\/jpet.105.098384","volume":"317","author":"C Medina","year":"2006","unstructured":"Medina C, Jurasz P, Santos-Martinez MJ, Jeong SS, Mitsky T, Chen R, et al. Platelet aggregation-induced by caco-2 cells: regulation by matrix metalloproteinase-2 and adenosine diphosphate. J Pharmacol Exp Ther. 2006;317:739\u201345.","journal-title":"J Pharmacol Exp Ther"},{"key":"1634_CR47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000166183","volume":"83","author":"Y Hua","year":"2009","unstructured":"Hua Y, Xue J, Sun F, Zhu L, Xie M. Aspirin inhibits MMP-2 and MMP-9 expressions and activities through upregulation of PPARalpha\/gamma and TIMP gene expressions in ox-LDL-stimulated macrophages derived from human monocytes. Pharmacology. 2009;83:18\u201325.","journal-title":"Pharmacology"},{"key":"1634_CR48","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10753-009-9125-3","volume":"32","author":"Y Yiqin","year":"2009","unstructured":"Yiqin Y, Meilin X, Jie X, Keping Z. Aspirin inhibits MMP-2 and MMP-9 expression and activity through PPARalpha\/gamma and TIMP-1-mediated mechanisms in cultured mouse celiac macrophages. Inflammation. 2009;32:233\u201341.","journal-title":"Inflammation"},{"key":"1634_CR49","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1006\/bbrc.2001.4637","volume":"282","author":"MC Jiang","year":"2001","unstructured":"Jiang MC, Liao CF, Lee PH. Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells. Biochem Biophys Res Commun. 2001;282:671\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"1634_CR50","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.biopha.2008.07.094","volume":"63","author":"CS Tsai","year":"2009","unstructured":"Tsai CS, Luo SF, Ning CC, Lin CL, Jiang MC, Liao CF. Acetylsalicylic acid regulates MMP-2 activity and inhibits colorectal invasion of murine B16F0 melanoma cells in C57BL\/6\u00a0J mice: effects of prostaglandin F(2)alpha. Biomed Pharmacother. 2009;63:522\u20137.","journal-title":"Biomed Pharmacother"},{"key":"1634_CR51","first-page":"267","volume":"27","author":"A Rabinovich","year":"2007","unstructured":"Rabinovich A, Medina L, Piura B, Segal S, Huleihel M. Regulation of ovarian carcinoma SKOV-3 cell proliferation and secretion of MMPs by autocrine IL-6. Anticancer Res. 2007;27:267\u201372.","journal-title":"Anticancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1634-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1634-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1634-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T05:29:11Z","timestamp":1567142951000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1634-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,9]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1634"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1634-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,9]]},"article-number":"627"}}